Laurent Chardonnet Prelude Therapeutics Inc (PRLD) insider trading activity

Laurent Chardonnet is Chief Financial Officer of Prelude Therapeutics Inc. Currently has a direct ownership of 42,165 shares of PRLD, which is worth approximately $54,814. The most recent transaction as insider was on May 23, 2023, when has been sold 5,000 shares (Common Stock) at a price of $5.5 per share, resulting in proceeds of $27,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.2K

0% 3M change

0% 12M change

Total Value Held $54,814

Laurent Chardonnet Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2023	BUY Open market or private purchase	$27,500 $5.5 p/Share	5,000 Added 10.6%	42,165 Common Stock
Dec 08 2022	BUY Open market or private purchase	$47,600 $4.76 p/Share	10,000 Added 21.8%	35,873 Common Stock
Jun 01 2022	BUY Open market or private purchase	$42,300 $4.23 p/Share	10,000 Added 28.99%	24,500 Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	$48,815 $7.51 p/Share	6,500 Added 30.95%	14,500 Common Stock
Dec 13 2021	BUY Grant, award, or other acquisition	$61,400 $12.28 p/Share	5,000 Added 38.46%	8,000 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Chief Financial Officer